Tenant Representation
ALLOGENE, INC. 70,000 sq. ft. HQ/R+D facility at 210 East Grand Avenue in South San Francisco and a 117,000 sq. ft. manufacturing facility at Gateway 84 in Newark
AMGEN INC. Over 500,000 s.f. of lease transactions in South San Francisco and Fremont
BAYER HEALTHCARE Relocation of a global research division into a new 55,000 s.f. facility at 455 Mission Bay Boulevard South in Mission Bay, San Francisco
BRISTOL-MYERS SQUIBB Strategic analysis of the market and the execution of a consolidation strategy for 133,000 s.f. in Redwood City; arranged subsequent expansions of 60,000 and 61,000 s.f. to create a 3-building campus of 255,000 s.f.
FIVEPRIME THERAPEUTICS Relocation and expansion of their HQ, laboratory and office facility into 116,000 s.f. at The Cove in South San Francisco
VERACYTE, INC. 56,000 s.f. relocation and expansion of their laboratory and office facilities at 6000 Shoreline Court in South San Francisco
NEKTAR THERAPEUTICS, INC. HQ and R&D relocation into a 102,000 s.f. facility at 455 Mission Bay Boulevard South in Mission Bay, San Francisco; subsequently arranged a renewal and expansion totaling 153,000 s.f. and a separate office expansion of 136,000 sq. ft. at 360 Third Street, San Francisco
PACIRA BIOSCIENCES, INC. In partnership with KM’s San Diego Life Science team, completed over 200,000 s.f. of leases for R&D, manufacturing and GMP warehouse facilities
PFIZER, INC. 100,000 s.f. lease transaction for a specialty R&D division into 455 Mission Bay Boulevard South in Mission Bay, San Francisco
BRISTOL-MYERS SQUIBB 60,000 s.f. lease transaction for a specialty oncology division at 395 Oyster Point Boulevard in South San Francisco
INSITE VISION 40,000 s.f. expansion and renewal of their laboratory and office facilities at 965 Atlantic and 2020 Challenger in Alameda
SIRNA THERAPEUTICS/MERK 67,000 SF in three transactions at 1700 Owens in Mission Bay, San Francisco